1. Home
  2. SYNX vs PMCB Comparison

SYNX vs PMCB Comparison

Compare SYNX & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYNX
  • PMCB
  • Stock Information
  • Founded
  • SYNX 2005
  • PMCB 1996
  • Country
  • SYNX Israel
  • PMCB United States
  • Employees
  • SYNX N/A
  • PMCB N/A
  • Industry
  • SYNX
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SYNX
  • PMCB Health Care
  • Exchange
  • SYNX Nasdaq
  • PMCB Nasdaq
  • Market Cap
  • SYNX 11.9M
  • PMCB 11.4M
  • IPO Year
  • SYNX 2024
  • PMCB N/A
  • Fundamental
  • Price
  • SYNX $1.85
  • PMCB $1.02
  • Analyst Decision
  • SYNX
  • PMCB
  • Analyst Count
  • SYNX 0
  • PMCB 0
  • Target Price
  • SYNX N/A
  • PMCB N/A
  • AVG Volume (30 Days)
  • SYNX 30.5K
  • PMCB 10.7K
  • Earning Date
  • SYNX 05-14-2025
  • PMCB 03-17-2025
  • Dividend Yield
  • SYNX N/A
  • PMCB N/A
  • EPS Growth
  • SYNX N/A
  • PMCB N/A
  • EPS
  • SYNX N/A
  • PMCB 1.29
  • Revenue
  • SYNX $9,094,000.00
  • PMCB N/A
  • Revenue This Year
  • SYNX N/A
  • PMCB N/A
  • Revenue Next Year
  • SYNX N/A
  • PMCB N/A
  • P/E Ratio
  • SYNX N/A
  • PMCB $0.81
  • Revenue Growth
  • SYNX 19.14
  • PMCB N/A
  • 52 Week Low
  • SYNX $1.70
  • PMCB $1.03
  • 52 Week High
  • SYNX $6.49
  • PMCB $2.42
  • Technical
  • Relative Strength Index (RSI)
  • SYNX 39.25
  • PMCB 39.25
  • Support Level
  • SYNX $1.82
  • PMCB $1.00
  • Resistance Level
  • SYNX $2.06
  • PMCB $1.17
  • Average True Range (ATR)
  • SYNX 0.13
  • PMCB 0.09
  • MACD
  • SYNX 0.07
  • PMCB -0.00
  • Stochastic Oscillator
  • SYNX 41.67
  • PMCB 20.38

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: